Anders Nyberg - Concepedia

Author

Anders Nyberg

Uppsala University Hospital ORCID

Also Known As

A Nyberg, A. NYBERG, A. Nyberg, A.H. Nyberg, Anders H Nyberg, Anders H. Nyberg, Anders Nyberg, Sara Petersson

Publications

Citations

H-Index

106

Concepts

All Affiliations

Uppsala University Hospital Uppsala University Sundsvall Municipality Kaiser Permanente National Board of Health and Welfare

About

Anders Nyberg is an author at Uppsala University Hospital specializing in medicine, gastroenterology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1.4K
2	Public Health	6	6	222
3	Health Sciences	3	3	309
4	Natural Sciences	2	2	53
5	Engineering	1	1	22

Anders Nyberg

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV Péter Ferenci, David Bernstein, Jacob Lalezari, New England Journal of Medicine	2014	690
Increased Serum Levels of Hyaluronate in Liver Disease Anna Engström‐Laurent, Lars Lööf, Anders Nyberg, Hepatology Endothelial CellsPathologyHepatotoxicityMicrovascular DysfunctionSerum Levels	1985	249
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis Robert Löfberg, Åke Danielsson, Ole B. Suhr, Gastroenterology InflammationLeft-sided Ulcerative ColitisAnti-inflammatoryGastroenterologySurgery	1996	190
Absence of Therapeutic Benefit from Antacids or Cimetidine in Non-Ulcer Dyspepsia Olof Nyrén, Hans‐Olov Adami, Sandra R. Bates, New England Journal of Medicine InflammationPain TherapyTherapeutic BenefitFunctional Gastrointestinal DisorderEpigastric Pain	1986	184
RAPID HEALING OF DUODENAL ULCERS WITH OMEPRAZOLE: DOUBLE-BLIND DOSE-COMPARATIVE TRIAL Sven Gustavsson, Lars Lööf, Hans‐Olov Adami, The Lancet Gastrointestinal PharmacologyGastroenterologyDouble-blind Dose-comparative TrialSurgeryUpper Gastrointestinal Surgery	1983	138
Serum hyaluronate in primary biliary cirrhosis—A biochemical marker for progressive liver damage Anders Nyberg, Anna Engström‐Laurent, Lars Lööf Hepatology	1988	137
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green, Gastroenterology Difference Between LatiglutenaseVillous AtrophyClinical PresentationCeliac DiseaseMedicine	2016	131
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C–Infected Patients With Compensated and Decompensated Cirrhosis Varun Saxena, Lisa M. Nyberg, Marypat Pauly, Hepatology	2015	109
Primary Biliary Cirrhosis: Clinical Features and Outcome, with Special Reference to Asymptomatic Disease Anders Nyberg, Lars Lööf Scandinavian Journal of Gastroenterology	1989	86
Social and economic effects of non-ulcer dyspepsia Olof Nryén, Hans‐Olov Adami, Sven Gustavsson, Scandinavian Journal of Gastroenterology MalnutritionEarly RetirementHealth OutcomeSocial Determinants Of HealthNon-ulcer Dyspepsia	1985	75

Page 1